Clinical Trial Update: A Study of REGEND003 on Patients With Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) [Phase 1]

View source ↗

Summary

Phase 1 clinical trial evaluating REGEND003 in adults with Type 2 diabetes mellitus and chronic kidney disease is currently recruiting. Sponsored by Regend Ther…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Type 2 Diabetes Mellitus

Drugs mentioned

• REGEND003

Snippet

Sponsor: Regend Therapeutics | Conditions: Type 2 Diabetes Mellitus (T2DM) and Chronic Kidney Disease (CKD) | Phase 1 | Status: RECRUITING